Earningsreport

Q2/2020 7/31/2019 EPS -0.200 ZacksConsensus -0.310 ActVsEst 0.110 - Beat

BIOPHARMX CORP  (BPMX) 
NASDAQ:AMEX Investor Relations: biopharmx.com